PKB/SGK-dependent GSK3-phosphorylation in the regulation of LPS-induced Ca2+ increase in mouse dendritic cells

Biochemical and Biophysical Research Communications

Volumn 437, Issue 3, 2013, Pages 336-341

  Russo, Antonella ^a   Schmid, Evi ^a   Nurbaeva, Meerim K ^a   Yang, Wenting ^a   Yan, Jing ^a   Bhandaru, Madhuri ^a   Faggio, Caterina ^b   Shumilina, Ekaterina ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Ca2+; Lipopolysaccharide; PI3 kinase; PKB Akt; SB216763; SGK

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; ALANINE; CALCIUM ION; FURA 2; GLYCOGEN SYNTHASE KINASE 3; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN KINASE B; SERINE; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; FLUORESCENCE; IMMUNOHISTOCHEMISTRY; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; WESTERN BLOTTING; WILD TYPE;

CA(2+); LIPOPOLYSACCHARIDE; PI3 KINASE; PKB/AKT; SB216763; SGK;

ANIMALS; CALCIUM SIGNALING; DENDRITIC CELLS; GENE KNOCK-IN TECHNIQUES; GLYCOGEN SYNTHASE KINASE 3; IMMEDIATE-EARLY PROTEINS; LIPOPOLYSACCHARIDES; MICE; MICE, MUTANT STRAINS; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; UP-REGULATION;

BACTERIA (MICROORGANISMS); MUS;

EID: 84880962366     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.06.075     Document Type: Article

References (40)

1. Beurel E., Jope R.S. The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. Prog. Neurobiol. 2006, 79:173-189.
2. Cohen P., Frame S. The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2001, 2:769-776.
3. Frame S., Cohen P. GSK3 takes centre stage more than 20years after its discovery. Biochem. J. 2001, 359:1-16.
4. Kaytor M.D., Orr H.T. The GSK3 beta signaling cascade and neurodegenerative disease. Curr. Opin. Neurobiol. 2002, 12:275-278.
5. Koros E., Dorner-Ciossek C. The role of glycogen synthase kinase-3beta in schizophrenia. Drug News Perspect. 2007, 20:437-445.
6. Jope R.S., Yuskaitis C.J., Beurel E. Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem. Res. 2007, 32:577-595.
7. Beurel E., Jope R.S. Glycogen synthase kinase-3 regulates inflammatory tolerance in astrocytes. Neuroscience 2010, 169:1063-1070.
8. Beurel E., Michalek S.M., Jope R.S. Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol. 2010, 31:24-31.
9. Beurel E., Yeh W.I., Michalek S.M., Harrington L.E., Jope R.S. Glycogen synthase kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells. J. Immunol. 2011, 186:1391-1398.
10. Wang H., Brown J., Martin M. Glycogen synthase kinase 3: a point of convergence for the host inflammatory response. Cytokine 2011, 53:130-140.
11. Wang H., Brown J., Garcia C.A., Tang Y., Benakanakere M.R., Greenway T., Alard P., Kinane D.F., Martin M. The role of glycogen synthase kinase 3 in regulating IFN-beta-mediated IL-10 production. J. Immunol. 2011, 186:675-684.
12. Wang H., Brown J., Gu Z., Garcia C.A., Liang R., Alard P., Beurel E., Jope R.S., Greenway T., Martin M. Convergence of the mammalian target of rapamycin complex 1- and glycogen synthase kinase 3-{beta}-signaling pathways regulates the innate inflammatory response. J. Immunol. 2011, 186:5217-5226.
13. Hofmann C., Dunger N., Scholmerich J., Falk W., Obermeier F. Glycogen synthase kinase 3-beta: a master regulator of toll-like receptor-mediated chronic intestinal inflammation. Inflamm. Bowel Dis. 2010, 16:1850-1858.
14. De Sarno P., Axtell R.C., Raman C., Roth K.A., Alessi D.R., Jope R.S. Lithium prevents and ameliorates experimental autoimmune encephalomyelitis. J. Immunol. 2008, 181:338-345.
15. Dugo L., Collin M., Allen D.A., Patel N.S., Bauer I., Mervaala E.M., Louhelainen M., Foster S.J., Yaqoob M.M., Thiemermann C. GSK-3beta inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat. Crit. Care Med. 2005, 33:1903-1912.
16. Hu X., Paik P.K., Chen J., Yarilina A., Kockeritz L., Lu T.T., Woodgett J.R., Ivashkiv L.B. IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity 2006, 24:563-574.
17. Martin M., Rehani K., Jope R.S., Michalek S.M. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 2005, 6:777-784.
18. Hughes K., Ramakrishna S., Benjamin W.B., Woodgett J.R. Identification of multifunctional ATP-citrate lyase kinase as the alpha-isoform of glycogen synthase kinase-3. Biochem. J. 1992, 288(Pt. 1):309-314.
19. Welsh G.I., Proud C.G. Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. Biochem. J. 1993, 294(Pt. 3):625-629.
20. Cross H.R., Radda G.K., Clarke K. The role of Na+/K+ ATPase activity during low flow ischemia in preventing myocardial injury: a 31P, 23Na and 87Rb NMR spectroscopic study. Magn. Reson. Med. 1995, 34:673-685.
21. Shaw M., Cohen P., Alessi D.R. Further evidence that the inhibition of glycogen synthase kinase-3beta by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216. FEBS Lett. 1997, 416:307-311.
22. Sakoda H., Gotoh Y., Katagiri H., Kurokawa M., Ono H., Onishi Y., Anai M., Ogihara T., Fujishiro M., Fukushima Y., Abe M., Shojima N., Kikuchi M., Oka Y., Hirai H., Asano T. Differing roles of Akt and serum- and glucocorticoid-regulated kinase in glucose metabolism, DNA synthesis, and oncogenic activity. J. Biol. Chem. 2003, 278:25802-25807.
23. Wyatt A.W., Hussain A., Amann K., Klingel K., Kandolf R., Artunc F., Grahammer F., Huang D.Y., Vallon V., Kuhl D., Lang F. DOCA-induced phosphorylation of glycogen synthase kinase 3beta. Cell. Physiol. Biochem. 2006, 17:137-144.
24. Hawkins P.T., Anderson K.E., Davidson K., Stephens L.R. Signaling through Class I PI3Ks in mammalian cells. Biochem. Soc. Trans. 2006, 34:647-662.
25. Lang F., Bohmer C., Palmada M., Seebohm G., Strutz-Seebohm N., Vallon V. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol. Rev. 2006, 86:1151-1178.
26. Ohtani M., Nagai S., Kondo S., Mizuno S., Nakamura K., Tanabe M., Takeuchi T., Matsuda S., Koyasu S. Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells. Blood 2008, 112:635-643.
27. Rodionova E., Conzelmann M., Maraskovsky E., Hess M., Kirsch M., Giese T., Ho A.D., Zoller M., Dreger P., Luft T. GSK-3 mediates differentiation and activation of proinflammatory dendritic cells. Blood 2007, 109:1584-1592.
28. Ono T., Yanagawa Y., Iwabuchi K., Nonomura K., Onoe K. Glycogen synthase kinase 3 activity during development of bone marrow-derived dendritic cells (DCs) essential for the DC function to induce T helper 2 polarization. Immunology 2007, 122:189-198.
29. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
30. Dubsky P., Ueno H., Piqueras B., Connolly J., Banchereau J., Palucka A.K. Human dendritic cell subsets for vaccination. J. Clin. Immunol. 2005, 25:551-572.
31. Escribano C., Delgado-Martin C., Rodriguez-Fernandez J.L. CCR7-dependent stimulation of survival in dendritic cells involves inhibition of GSK3beta. J. Immunol. 2009, 183:6282-6295.
32. Shumilina E., Huber S.M., Lang F. Ca2+ signaling in the regulation of dendritic cell functions. Am. J. Physiol. Cell Physiol. 2011, 300:C1205-C1214.
33. McManus E.J., Sakamoto K., Armit L.J., Ronaldson L., Shpiro N., Marquez R., Alessi D.R. Role that phosphorylation of GSK3 plays in insulin and Wnt Signaling defined by knockin analysis. EMBO J. 2005, 24:1571-1583.
34. Boini K.M., Bhandaru M., Mack A., Lang F. Steroid hormone release as well as renal water and electrolyte excretion of mice expressing PKB/SGK-resistant GSK3. Pflugers Arch. 2008, 456:1207-1216.
35. Boini K.M., Amann K., Kempe D., Alessi D.R., Lang F. Proteinuria in mice expressing PKB/SGK-resistant GSK3. Am. J. Physiol. Renal Physiol. 2009, 296:F153-F159.
36. Rotte A., Pasham V., Eichenmuller M., Yang W., Qadri S.M., Bhandaru M., Lang F. Regulation of basal gastric acid secretion by the glycogen synthase kinase GSK3. J. Gastroenterol. 2010, 45:1022-1032.
37. Siraskar B., Volkl J., Ahmed M.S., Hierlmeier M., Gu S., Schmid E., Leibrock C., Foller M., Lang U.E., Lang F. Enhanced catecholamine release in mice expressing PKB/SGK-resistant GSK3. Pflugers Arch. 2011, 462:811-819.
38. Ackermann T.F., Kempe D.S., Lang F., Lang U.E. Hyperactivity and enhanced curiosity of mice expressing PKB/SGK-resistant glycogen synthase kinase-3 (GSK-3). Cell. Physiol. Biochem. 2010, 25:775-786.
39. Martin D.R., Ritter C.S., Slatopolsky E., Brown A.J. Acute regulation of parathyroid hormone by dietary phosphate. Am. J. Physiol. Endocrinol. Metab. 2005, 289:E729-E734.
40. Bhavsar S.K., Merches K., Bobbala D., Lang F. AKT/SGK-sensitive phosphorylation of GSK3 in the regulation of L-selectin and perforin expression as well as activation induced cell death of T-lymphocytes. Biochem. Biophys. Res. Commun. 2012, 425:6-12.